Word

BIOTRILLION

Status

Pending

Status Code

688

Status Date

Tuesday, October 31, 2023

Serial Number

97261958

Mark Type

4000

Filing Date

Thursday, February 10, 2022

Published for Opposition

Tuesday, September 5, 2023

Trademark Owner History

BioTrillion, Inc. - Owner At Publication

Classifications

9 downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data

42 Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug use

Trademark Events

Oct 31, 2023

Noa E-Mailed - Sou Required From Applicant

Sep 5, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2023

Published For Opposition

Aug 16, 2023

Notification Of Notice Of Publication E-Mailed

Jul 29, 2023

Approved For Pub - Principal Register

Jul 4, 2023

Teas/Email Correspondence Entered

Jul 3, 2023

Correspondence Received In Law Office

Jul 3, 2023

Teas Response To Office Action Received

Apr 6, 2023

Notification Of Non-Final Action E-Mailed

Apr 6, 2023

Non-Final Action E-Mailed

Apr 6, 2023

Non-Final Action Written

Mar 6, 2023

Teas/Email Correspondence Entered

Mar 6, 2023

Correspondence Received In Law Office

Mar 6, 2023

Teas Response To Office Action Received

Dec 5, 2022

Notification Of Non-Final Action E-Mailed

Dec 5, 2022

Non-Final Action E-Mailed

Dec 5, 2022

Non-Final Action Written

Nov 23, 2022

Assigned To Examiner

Feb 15, 2022

New Application Office Supplied Data Entered

Feb 14, 2022

New Application Entered